Radionuclide ventriculography to evaluate myocardial function.
Developments over the past decade have allowed one to visualize the right and left ventricles using radionuclide techniques and to study the influence of a wide range of physiologic, pharmacologic and surgical interventions on global and regional ventricular function thereby providing important diagnostic insight and improved therapeutic capabilities. These tests are relatively non-invasive, they can be performed serially, they may be performed in patients that are seriously ill, and they have no recognized risk other than low level radiation exposure. With continued improvement in noninvasive imaging and processing and in the sophistication of associated computer systems, one may expect significant and wide ranging additional contributions in the assessment of myocardial function using radionuclide ventriculographic techniques.
D002302:Cardiac Output; D003327:Coronary Disease / Q000175:diagnosis / Q000000981:diagnostic imaging; D003971:Diastole; D005080:Exercise Test; D006321:Heart / Q000000981:diagnostic imaging*; D006333:Heart Failure / Q000000981:diagnostic imaging; D006349:Heart Valve Diseases / Q000000981:diagnostic imaging; D006352:Heart Ventricles / Q000000981:diagnostic imaging; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging; D010146:Pain / Q000209:etiology; D011877:Radionuclide Imaging; D013670:Sodium Pertechnetate Tc 99m; D013318:Stroke Volume / Q000187:drug effects; D013599:Systole; D013667:Technetium; D013909:Thorax; D016276:Ventricular Function
D013667:Technetium; D013670:Sodium Pertechnetate Tc 99m